INNOVATIVE PRODUCTIVITY AND RETURNS TO SCALE IN THE PHARMACEUTICAL-INDUSTRY

被引：136

作者：

GRAVES, SB ^{[1
]}

LANGOWITZ, NS ^{[1
]}

机构：

[1] BABSON COLL,SCH MANAGEMENT,BABSON PK,MA 02157

来源：

STRATEGIC MANAGEMENT JOURNAL | 1993年 / 14卷 / 08期

关键词：

INNOVATION; RESEARCH AND DEVELOPMENT; ECONOMIES OF SCALE;

D O I：

10.1002/smj.4250140803

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

This study shows that firms in the pharmaceutical industry experience decreasing returns to scale in R&D as the level of R&D expenditures rises. The paper presents the results of our study of the innovative output of 16 pharmaceutical firms over a 19 year period. Given the strong correlation between R&D budgets and firm size, our study suggests the wave of mergers in the industry may yield less innovative productivity than managers expect.

引用

页码：593 / 605

页数：13

共 34 条

[1]

Acs Z.J., 1990, INNOVATION SMALL FIR

[2]

ACS ZJ, 1988, AM ECON REV, V78, P678

[3] INNOVATION, MARKET-STRUCTURE, AND FIRM SIZE [J].

ACS, ZJ ;

AUDRETSCH, DB .

REVIEW OF ECONOMICS AND STATISTICS, 1987, 69 (04) :567-574

[4]

ADAMS W, 1986, BRIGNESS COMPLEX

[5]

BREMNER B, 1991, BUSINESS WEEK 1014, P86

[6]

COMANOR WS, 1986, J ECON LIT, V24, P1178

[7] RESEARCH AND TECHNICAL CHANGE IN THE PHARMACEUTICAL-INDUSTRY [J].

COMANOR, WS .

REVIEW OF ECONOMICS AND STATISTICS, 1965, 47 (02) :182-190

[8]

DEHAEN P, 1969, NEW PRODUCT SURVE

[9]

Dertouzos Michael, 1989, MADE AM REGAINING PR

[10]

DOWNS A, 1967, BUREAUCRACY

← 1 2 3 4 →